Ms Sharon Lamb > McDermott Will & Emery UK LLP > London, England > Lawyer Profile
McDermott Will & Emery UK LLP Offices

22 Bishopsgate
London
EC2N 4BQ
England
- Firm Profile
- Go to...
Ms Sharon Lamb

Work Department
Healthcare
Position
Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector and is Head of McDermott’s UK Healthcare Practice Group.
Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devices, digital health and health data.
Visit our website for more: https://www.mwe.com/people/lamb-sharon/
Memberships
Sharon is senior associate fellow of the Nuffield Trust
Education
University of Cape Town, LLB, 1995
University of Cape Town, BComm, 1992
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Leading partners)Lauded for advice that ‘balances the risks and benefits of any given approach clearly’, McDermott Will & Emery UK LLP is active across regulatory matters such as medical device certifications and transactional work spanning M&A, IP transfers and growth capital investments. Sharon Lamb heads up the team and has a far-reaching practice spanning commercial, regulatory and transactional expertise. Bella North is also recommended.
Lawyer Rankings
- Leading partners London > Industry focus > Life sciences and healthcare
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
Firm Rankings
- Dispute resolution > Commercial litigation: mid-market
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Private client > Personal tax, trusts and probate
- Finance > Acquisition finance
- Finance > Derivatives and structured products
- Risk advisory > ESG
- Finance > High yield
- Dispute resolution > International arbitration
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Real estate > Property finance
- Projects, energy and natural resources > Renewables
- Employment > Employers